Pediatric phase I and pharmacokinetic study of erlotinib followed by the combination of erlotinib and temozolomide: a Children’s Oncology Group Phase I Consortium Study - Jakacki, R I; Hamilton, M; Gilbertson, R J (J Clin Oncol, 2008)
et al.